Prelude Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,900
Closed -$1.3M 1046
2025
Q1
$1.3M Sell
4,900
-600
-11% -$148K 0.1% 250
2024
Q4
$1.28M Buy
+5,500
New +$1.26M 0.08% 313
2021
Q2
Sell
-35,000
Closed -$7.15M 1678
2021
Q1
$7.15M Hold
35,000
0.18% 68
2020
Q4
$6.37M Buy
+35,000
New +$5.95M 0.16% 72
2019
Q2
Sell
-5,000
Closed -$823K 1731
2019
Q1
$823K Buy
+5,000
New +$884K 0.05% 373

Other funds holding CME

Prelude Capital Management's CME Position: Q1 2026 in Review

Prelude Capital Management opened a new position in CME Group (CME) in Q1 2026: 976 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #726 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in CME as recently as Q2 2025.

Prelude Capital Management first reported a position in CME in Q1 2015 and has held it in 23 quarters since. The position peaked at $4.3M in Q3 2018. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Prelude Capital Management held 976 shares of CME Group worth $288K as of Q1 2026.
  • CME Group was a new Prelude Capital Management position in Q1 2026.
  • CME Group made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #726 holding.
  • Prelude Capital Management first reported a position in CME Group in Q1 2015 and has held it in 23 quarters since.
  • Prelude Capital Management's CME Group position peaked at $4.3M in Q3 2018.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.